The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.
Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused ...
Dosing Initiated in a Phase 1 Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor in Development for the Treatment of Chronic ...
With dozens of competing brands and products lining the shelves of the supplement aisle at your local pharmacy or grocery store, finding the right vitamin or supplement can be overwhelming.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results